Literature DB >> 23982595

Glyoxalase 1 as a candidate for indicating the metastatic potential of SN12C human renal cell carcinoma cell clones.

Toshiyuki Tanaka1, Yasuhiro Kuramitsu, Yufeng Wang, Byron Baron, Takao Kitagawa, Kazuhiro Tokuda, Kosei Hirakawa, Masakazu Yashiro, Seiji Naito, Kazuyuki Nakamura.   

Abstract

Three clones with differential metastatic potential were established from the parental SN12C human renal cell carcinoma (HRCC). We previously reported that in the two high metastatic SN12C clones, two isoforms of ubiquitin carboxyl-terminal hydrolase isozyme L1 (UCH‑L1) showed decreased expression by using two-dimensional electrophoresis (2‑DE) covering a pH range (pH 3.0‑10.0) followed by liquid chromatography‑tandem mass spectrometry. However, in the case of the low metastatic clone, the spot volume for UCH‑L1 was almost the same as for the parental SN12C. In the present study, we found one protein spot which was correlated with the metastatic potential of SN12C clones by using 2‑DE over a narrow pH range (pH 4.0‑7.0). The protein glyoxalase 1 (GLO1) appeared to be directly proportional to the metastatic potential of the SN12C clones. GLO1 was the only protein which consistently varied according to the metastatic potentials of SN12C clones. GLO1 was increased in high metastatic cell lines by western blot analysis. These findings suggest that GLO1 is associated with the metastatic potential of SN12C HRCC clones. We expanded our experimental range to include clones of scirrhous gastric cancer cell lines (OCUM‑2M, OCUM‑2D and OCUM‑2MLN) and similar results were obtained, thereby further strengthening our original findings.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23982595     DOI: 10.3892/or.2013.2699

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  6 in total

1.  Polymorphisms of the receptor for advanced glycation end-products and glyoxalase I in patients with renal cancer.

Authors:  Matúš Chocholatý; Marie Jáchymová; Marek Schmidt; Klára Havlová; Anna Křepelová; Tomáš Zima; Marko Babjuk; Marta Kalousová
Journal:  Tumour Biol       Date:  2014-11-19

2.  Expression of PGAM1 in renal clear cell carcinoma and its clinical significance.

Authors:  Chunjing Li; Fangpeng Shu; Bin Lei; Daojun Lv; Shoubo Zhang; Xiangming Mao
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

3.  High expression of pituitary tumor-transforming gene-1 predicts poor prognosis in clear cell renal cell carcinoma.

Authors:  Can Wei; Xiaoliang Yang; Junhua Xi; Wei Wu; Zhenxing Yang; Wei Wang; Zhiguo Tang; Quansheng Ying; Yanbin Zhang
Journal:  Mol Clin Oncol       Date:  2014-12-18

4.  Glo1 genetic amplification as a potential therapeutic target in hepatocellular carcinoma.

Authors:  Shirong Zhang; Xiaodong Liang; Xiaoliang Zheng; Haixiu Huang; Xufeng Chen; Kan Wu; Bing Wang; Shenglin Ma
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

5.  Potent apoptosis-inducing activity of erypoegin K, an isoflavone isolated from Erythrina poeppigiana, against human leukemia HL-60 cells.

Authors:  Kiyomi Hikita; Natsuki Hattori; Aya Takeda; Yuko Yamakage; Rina Shibata; Saori Yamada; Kuniki Kato; Tomiyasu Murata; Hitoshi Tanaka; Norio Kaneda
Journal:  J Nat Med       Date:  2017-11-18       Impact factor: 2.343

Review 6.  Glyoxalases in Urological Malignancies.

Authors:  Cinzia Antognelli; Vincenzo Nicola Talesa
Journal:  Int J Mol Sci       Date:  2018-01-31       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.